BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 12861029)

  • 1. Defective T-cell activation is associated with augmented transforming growth factor Beta sensitivity in mice with mutations in the Sno gene.
    Pearson-White S; McDuffie M
    Mol Cell Biol; 2003 Aug; 23(15):5446-59. PubMed ID: 12861029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGF-beta 1 differentially regulates IL-2 expression and [3H]-thymidine incorporation in CD3 epsilon mAb- and CD28 mAb-activated splenocytes and thymocytes.
    McKarns SC; Kaminski NE
    Immunopharmacology; 2000 Jul; 48(2):101-15. PubMed ID: 10936508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor-beta- and Activin-Smad signaling pathways are activated at distinct maturation stages of the thymopoeisis.
    Rosendahl A; Speletas M; Leandersson K; Ivars F; Sideras P
    Int Immunol; 2003 Dec; 15(12):1401-14. PubMed ID: 14645149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Embryonic age influences the capacity for cytokine induction in chicken thymocytes.
    Peters MA; Browning GF; Washington EA; Crabb BS; Kaiser P
    Immunology; 2003 Nov; 110(3):358-67. PubMed ID: 14632664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disrupting the IL-4 gene rescues mice homozygous for the tight-skin mutation from embryonic death and diminishes TGF-beta production by fibroblasts.
    Kodera T; McGaha TL; Phelps R; Paul WE; Bona CA
    Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3800-5. PubMed ID: 11891315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smad3 is essential for TGF-beta 1 to suppress IL-2 production and TCR-induced proliferation, but not IL-2-induced proliferation.
    McKarns SC; Schwartz RH; Kaminski NE
    J Immunol; 2004 Apr; 172(7):4275-84. PubMed ID: 15034041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The murine gastrin promoter is synergistically activated by transforming growth factor-beta/Smad and Wnt signaling pathways.
    Lei S; Dubeykovskiy A; Chakladar A; Wojtukiewicz L; Wang TC
    J Biol Chem; 2004 Oct; 279(41):42492-502. PubMed ID: 15292219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of DNA synthesis and IL-2 bioactivity in MLR by splenic pregnancy-associated natural suppressor cells involves the production of a TGF-beta 1-like molecule and a second distinct inhibitory factor.
    Brooks-Kaiser JC; Hoskin DW
    J Reprod Immunol; 1993 Sep; 25(1):31-49. PubMed ID: 8271238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of early chicken thymocyte proliferation by transforming growth factor-beta from thymic stromal cells and thymocytes.
    Mukamoto M; Kodama H
    Vet Immunol Immunopathol; 2000 Nov; 77(1-2):121-32. PubMed ID: 11068070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PU.1 is a lineage-specific regulator of tyrosine phosphatase CD45.
    Anderson KL; Nelson SL; Perkin HB; Smith KA; Klemsz MJ; Torbett BE
    J Biol Chem; 2001 Mar; 276(10):7637-42. PubMed ID: 11114304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomodulatory effects of transforming growth factor-beta on T lymphocytes. Induction of CD8 expression in the CTLL-2 cell line and in normal thymocytes.
    Inge TH; McCoy KM; Susskind BM; Barrett SK; Zhao G; Bear HD
    J Immunol; 1992 Jun; 148(12):3847-56. PubMed ID: 1602133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrasting effect of transforming growth factor type beta 1 (TGF-beta 1) on proliferation and interleukin-2 receptor expression in activated and rapidly cycling immature (CD3-CD4-CD8-) thymocytes.
    Dupuy d'Angeac A; Rème T; Monier S; Gao Q; Duperray C; Jullien P; Dornand J
    J Cell Physiol; 1993 Jan; 154(1):44-52. PubMed ID: 8419406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory effects of transforming growth factor-beta on IL-2- and IL-4-dependent T cell-cycle progression.
    Ruegemer JJ; Ho SN; Augustine JA; Schlager JW; Bell MP; McKean DJ; Abraham RT
    J Immunol; 1990 Mar; 144(5):1767-76. PubMed ID: 2407783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smad4/DPC4-dependent regulation of biglycan gene expression by transforming growth factor-beta in pancreatic tumor cells.
    Chen WB; Lenschow W; Tiede K; Fischer JW; Kalthoff H; Ungefroren H
    J Biol Chem; 2002 Sep; 277(39):36118-28. PubMed ID: 12140283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional regulation of tristetraprolin by transforming growth factor-beta in human T cells.
    Ogawa K; Chen F; Kim YJ; Chen Y
    J Biol Chem; 2003 Aug; 278(32):30373-81. PubMed ID: 12754205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early human thymocyte proliferation is regulated by an externally controlled autocrine transforming growth factor-beta 1 mechanism.
    Mossalayi MD; Mentz F; Ouaaz F; Dalloul AH; Blanc C; Debré P; Ruscetti FW
    Blood; 1995 Jun; 85(12):3594-601. PubMed ID: 7780143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-stimulation of T cell proliferation by transforming growth factor-beta 1.
    Lee HM; Rich S
    J Immunol; 1991 Aug; 147(4):1127-33. PubMed ID: 1831218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. beta-Catenin expression enhances generation of mature thymocytes.
    Mulroy T; Xu Y; Sen JM
    Int Immunol; 2003 Dec; 15(12):1485-94. PubMed ID: 14645157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restoration of transforming growth factor-beta signaling enhances radiosensitivity by altering the Bcl-2/Bax ratio in the p53 mutant pancreatic cancer cell line MIA PaCa-2.
    Ahmed MM; Alcock RA; Chendil D; Dey S; Das A; Venkatasubbarao K; Mohiuddin M; Sun L; Strodel WE; Freeman JW
    J Biol Chem; 2002 Jan; 277(3):2234-46. PubMed ID: 11694525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of Sno expression in malignant melanoma.
    Poser I; Rothhammer T; Dooley S; Weiskirchen R; Bosserhoff AK
    Int J Oncol; 2005 May; 26(5):1411-7. PubMed ID: 15809735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.